Skip Nav Destination
Article navigation
Critical Care Medicine|
September 1990
A379 INHIBITION OF HUMAN LIVER ALFENTANIL METABOLISM BY MEDETOMIDINE STEREOISOMERS
H. F. Hill, PhD;
H. F. Hill, PhD
Depts. of Anesthesiology, Medicinal Chemistry and Surgery*, Univ. of Washington, and Division of Clinical Research, Fred Hutchinson Cancer Research Center†, Seattle, WA
Search for other works by this author on:
A. C. Eddy, MD
A. C. Eddy, MD
Depts. of Anesthesiology, Medicinal Chemistry and Surgery*, Univ. of Washington, and Division of Clinical Research, Fred Hutchinson Cancer Research Center†, Seattle, WA
Search for other works by this author on:
Anesthesiology September 1990, Vol. 73, NA.
Citation
E. D. Kharasch, H. F. Hill, A. C. Eddy; A379 INHIBITION OF HUMAN LIVER ALFENTANIL METABOLISM BY MEDETOMIDINE STEREOISOMERS. Anesthesiology 1990; 73:NA doi: https://doi.org/10.1097/00000542-199009001-00376
Download citation file:
49
Views
Citing articles via
Most Viewed
Related Articles
Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5
Anesthesiology (March 2005)
From Bench to Bedside and Back Again: A Personal Journey with Dexmedetomidine
Anesthesiology (September 2016)
Assessment of Cytochrome P450 3A4 Activity during the Menstrual Cycle Using Alfentanil as a Noninvasive Probe
Anesthesiology (July 1997)
The Role of Cytochrome P450 3A4 in Alfentanil Clearance : Implications for Interindividual Variability in Disposition and Perioperative Drug Interactions
Anesthesiology (July 1997)
Alpha-2 Adrenoceptor Agonists Decrease Cyclic Guanosine 3',5'-Monophosphate in the Mouse Brain
Anesthesiology (September 1996)
